Detalles de la búsqueda
1.
A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment.
Gynecol Oncol
; 185: 83-94, 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377762
2.
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Gynecol Oncol
; 182: 63-69, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262240
3.
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.
Semin Cancer Biol
; 86(Pt 2): 709-719, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35259492
4.
Sequential modulation of the Wnt/ß-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.
Gynecol Oncol
; 164(1): 170-180, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844776
5.
High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile.
Int J Clin Oncol
; 27(2): 323-331, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038071
6.
Long-Term Glucose Restriction with or without Beta-Hydroxybutyrate Enrichment Distinctively Alters Epithelial-Mesenchymal Transition-Related Signaling in Ovarian Cancer Cells.
Nutr Cancer
; 74(3): 808-809, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459685
7.
Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC.
Cancer Lett
; 586: 216681, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38311054
8.
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors.
Mol Oncol
; 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38037739
9.
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
Front Oncol
; 13: 1253629, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795442
10.
Metabolic Alterations and WNT Signaling Impact Immune Response in HGSOC.
Clin Cancer Res
; 28(7): 1433-1445, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031546
11.
Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies.
Cancers (Basel)
; 13(7)2021 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33918476
12.
Strategies in Overcoming Homologous Recombination Proficiency and PARP Inhibitor Resistance.
Mol Cancer Ther
; 20(9): 1542-1549, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34172532
13.
Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer.
Cancer Med
; 10(22): 8238-8250, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34729947
14.
Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology.
J Tissue Eng
; 12: 20417314211055015, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820113
Resultados
1 -
14
de 14
1
Próxima >
>>